Morgan Sanford
Head of Investor Relations
Replay available
Agios Pharmaceuticals, Inc. (AGIO) Q3 2025 Earnings Call
Agios Pharmaceuticals, Inc. (NASDAQ: AGIO) Q3 2025 earnings conference call, held 2025-10-30. Replay captured from the company's public earnings webcast.
Hosted by
Featured presenters
Brian Goss
Chief Executive Officer
Cecilia Jones
Chief Financial Officer
Sveta Milanova
Chief Commercial Officer
Dr. Sarah Huynh
Chief Medical Officer & Head of Research and Development
Eric Schmidt
Analyst, Cantor
Alex Stranahan
Analyst, Bank of America
Emily Bodnar
Analyst, H.C. Wainwright & Co.
Investor webinar replay
Watch the replay and follow the connected company analysis, news, and investor updates for Agios Pharmaceuticals, Inc..
Replay transcript excerpt
WEBVTT 00:00:00.031 -- 00:00:05.439 Good morning and welcome to AGO's Pharmaceuticals Third Quarter 2025 conference call. 00:00:05.439 -- 00:00:08.563 At this time, all participants are in a listen-only mode. 00:00:08.563 -- 00:00:11.368 There will be a question and answer session at the end. 00:00:11.368 -- 00:00:15.253 Please be advised that this call is being recorded at AGO's request. 00:00:15.253 -- 00:00:19.620 I would now like to turn the call over to Morgan Sanford, Head of Investor Relations 00:00:19.620 -- 00:00:23.082 at AGO. Please go ahead, ma'am. 00:00:23.145 -- 00:00:25.782 Thank you, Operator. Good morning, everyone. 00:00:25.782 -- 00:00:31.428 Thank you for joining us to discuss Agios Pharmaceuticals' third quarter 2025 financial 00:00:31.428 -- 00:00:36.614 results and business highlights. You can access the slides for today's call by going 00:00:36.614 -- 00:00:40.518 to the Investors section of our website, agios.com. 00:00:40.518 -- 00:00:45.163 Next slide, please. Please note we'll be making certain forward-looking statements today. 00:00:45.163 -- 00:00:49.828 Actual events and results could differ materially from those expressed or implied by 00:00:49.828 -- 00:00:54.942 any forward-looking statements because of various risks, uncertainties, and other factors. 00:00:54.942 -- 00:00:59.988 including those set forth in our most recent filings with the SEC and any other future 00:00:59.988 -- 00:01:05.335 filings that we may make with the SEC. Our third quarter earnings call agenda 00:01:05.335 -- 00:01:10.662 is shown on the next slide. Joining me on today's call are Brian Goss, 00:01:10.662 -- 00:01:16.189 Chief Executive Officer, Cecilia Jones, Chief Financial Officer, Sveta 00:01:16.189 -- 00:01:19.393 Milanova, Chief Commercial Officer, and...